Issue a 12-month labor-hour type call order under BPA HHSF223201810005B for subject matter expert and technical expert strategic advice for cfsan's standards of
Ended Awarded Last action
- Contract number
- 75F40123F19272
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $271,019
Award facts
- Contract value 100% obligated
- $271,019.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Berwyn Heights, MD 20740, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$60 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $271,080 |
About this award
FDA issued a 12-month labor-hour BPA call to Brillient Corporation under the GSA Multiple Award Schedule on March 29, 2023, with a ceiling value of $271,019.38. The call was set aside as Competitive 8(a) and provides subject matter expert and technical expert strategic advice for the Center for Food Safety and Applied Nutrition's Standards of Identity program.
Work is performed in Berwyn Heights, Maryland. The call's period of performance was extended by 5 months via no-cost bilateral modification, with ultimate completion in August 2024.
Service Contract Inventory reporting shows invoiced labor of $48,000 in FY2023 (2 contractor hours) and $195,000 in FY2024 (0.3 FTEs, 585 contractor hours). Brillient self-performed all reported hours with no subcontractor involvement. Government-paid hourly rates declined from $24,213.50 per hour in FY2023 to $333.27 per hour in FY2024, reflecting the likely front-loading of a small number of high-value advisory sessions in the opening months followed by standard-rate labor in subsequent periods.
Quick answers
Who was awarded contract 75F40123F19272?
75F40123F19272 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on March 29, 2023.
How much is contract 75F40123F19272 worth?
The government has obligated $271,019 on 75F40123F19272.
Is contract 75F40123F19272 an order under another contract?
Yes. 75F40123F19272 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19272 competed?
The extent of competition for 75F40123F19272 was full and open competition. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award